HUTCHMED to sell non-core JV for $608m to focus on oncology

HUTCHMED (China) Limited has taken a bold step in streamlining its operations by divesting its 45% equity interest in Shanghai Hutchison Pharmaceuticals Limited (SHPL) for ... Read More